Most accurate ultrasound test could detect 96% of ovarian cancers
An ultrasound test that detected 96% of ovarian cancers in postmenopausal women should replace the current standard of care test in the UK, according to a new study by BHP members.
In a paper publ…
Birmingham opens Europe’s first pancreatic cancer mRNA vaccine trial
Researchers at BHP founding-members University Hospitals Birmingham NHS Foundation Trust (UHB) and the University of Birmingham have opened a trial to study how messenger RNA (mRNA) cancer vaccines m…
Birmingham Health Partners Centre for Regulatory Science and Innovation director appointed
Leading AI healthcare expert Professor Alastair Denniston has been appointed Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation (BHP-CRSI).
Professor Denniston…
BHP welcomes Birmingham Community Healthcare to strategic research alliance
Birmingham Community Healthcare NHS Foundation Trust (BCHC) has become the sixth NHS member of Birmingham Health Partners – and its ninth overall – adding crucial community care to the city’s strateg…
‘Symptom triggered’ test can detect early-stage aggressive ovarian cancer in 1 in 4 cases
Symptom triggered testing, prompted by symptoms such as pain, abdominal bloating/swelling, and feeling full soon after starting to eat, can pick up early-stage aggressive ovarian cancer in 1 in 4 of…
Birmingham launches pioneering trial to improve pregnancy outcomes for severe haemolytic disease
A pioneering study that took place at Birmingham Women’s Hospital has found an antibody that can improve the survival rate of unborn babies with rare, early-onset fetal anaemia, as a result of haemol…